Icon Star Allu Arjun recently expressed his pride and appreciation for his fans who took up the initiative of organizing an HPV vaccine awareness campaign. Earlier, he had encouraged his fans to engage in at least one social service activity each year, and this year, they chose to focus on spreading awareness about the importance of the HPV vaccine. Allu Arjun shared a post on social media, praising their efforts and expressing how happy he was to see them carry out such a meaningful social i

On April 10, 2026, Shri Nandamuri Balakrishna inaugurated the ISDE India Edition 2026 conference on esophageal cancer in Hyderabad. This historic event, hosted by the International Society for Diseases of the Esophagus (ISDE) in collaboration with Basavatarakam Indo-American Cancer Hospital & Research Institute (BIACH&RI), marked the first time the conference was held in India. The event also commemorated BIACH&RI’s Silver Jubilee, celebrating 25 years of dedication to cancer ca

India’s pharmaceutical industry is poised for a massive shift as the patent for semaglutide, the active ingredient behind blockbuster drugs like Ozempic and Wegovy, expires on March 20, 2026. This marks the beginning of what experts are calling an unprecedented "generic wave". Within days, over 50 branded generic versions of semaglutide are expected to flood the Indian market, sparking one of the most significant pharmaceutical launches in recent history.

Prime Minister Narendra Modi is set to launch a nationwide HPV (Human Papillomavirus) vaccination campaign on February 28, 2026, aiming to combat cervical cancer, one of the leading causes of cancer-related deaths among women in India. This significant initiative will provide free vaccinations to 14-year-old girls at government health centers across the country, marking a major step forward in India’s preventive healthcare efforts. Key Deta

India is witnessing an unexpected reproductive shift as GLP-1 weight loss drugs such as Mounjaro, Wegovy, and Ozempic gain popularity across the country. Doctors in major cities are reporting a rise in unexpected pregnancies among women who had previously struggled with infertility. These surprise pregnancies, often referred to as "Ozempic babies" globally, are now being observed in India, just months after GLP-1 injectables entered the market. Originally designed for managing type 2 diabetes